4.4 Article

Phospholipid transfer protein deficiency in mice impairs macrophage reverse cholesterol transport in vivo

Journal

EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 241, Issue 13, Pages 1466-1472

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/1535370216641218

Keywords

Phospholipid transfer protein; reverse cholesterol transport; high-density lipoprotein

Funding

  1. Natural Science Foundations of China [81070247, 31300639]
  2. Shandong Provincial Natural Science Fund [ZR2013HL063]
  3. Shandong Provincial Key Research and Development Program [2015GSF119008]
  4. Tai'an City Research and Development planning [201440774-03]

Ask authors/readers for more resources

Phospholipid transfer protein is expressed in various cell types and secreted into plasma, where it transfers phospholipids between lipoproteins and modulates the composition of high-density lipoprotein particles. Phospholipid transfer protein deficiency in vivo can lower high-density lipoprotein cholesterol level significantly and impact the biological quality of high-density lipoprotein. Considering high-density lipoprotein was a critical determinant for reverse cholesterol transport, we investigated the role of systemic phospholipid transfer protein deficiency in macrophage reverse cholesterol transport in vivo. After the littermate phospholipid transfer protein KO and WT mice were fed high-fat diet for one month, they were injected intraperitoneally with H-3-cholesterol-labeled and acLDL-loaded macrophages. Then the appearance of H-3-tracer in plasma, liver, bile, intestinal wall, and feces over 48 h was determined. Plasma lipid analysis indicated phospholipid transfer protein deficiency lowered total cholesterol, high-density lipoprotein-C and apolipoprotein A1 levels significantly but increased triglyceride level in mice. The isotope tracing experiment showed H-3-cholesterol of plasma was decreased by 68% for male and 62% for female, and H-3-tracer of bile was decreased by 37% for male and 21% for female in phospholipid transfer protein KO mice compared with WT mice. However, there was no difference in liver, and H-3-tracer of intestinal wall was increased by 43% for male and 27% for female. Finally, H-3-tracer of fecal excretion in phospholipid transfer protein KO mice was reduced significantly by 36% for male and 43% for female during 0-24 h period, but there was no significant difference during 24-48 h period. Meanwhile, Western Blot analysis showed the expressions of reverse cholesterol transport -related protein liver X receptor alpha (LXR alpha), ATP binding cassette transporter A1, and cholesterol 7 alpha-hydroxylase A1 were upregulated in liver of phospholipid transfer protein KO mice compared with WT mice. These data reveal that systemic phospholipid transfer protein deficiency in mice impairs macrophage-specific reverse cholesterol transport in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available